BioCentury
ARTICLE | Company News

CSL, Patrys deal

February 8, 2010 8:00 AM UTC

Patrys granted CSL an exclusive, worldwide license to develop products based on two undisclosed antibodies and an exclusive option to select up to two additional early-stage antibodies. Patrys will re...